GDH (Glutamate Dehydrogenase) in Clostridioides difficile Diagnosis
GDH stands for glutamate dehydrogenase, a highly conserved metabolic enzyme present in all strains of Clostridioides difficile (both toxigenic and non-toxigenic), used as a rapid screening test that must always be paired with toxin detection because it cannot distinguish between disease-causing and harmless strains. 1
What GDH Detects
GDH is a common antigen enzyme found in high levels in all C. difficile isolates 1. The test detects this metabolic enzyme through immunoassay (typically EIA), providing rapid results that help screen for the presence of the organism 2.
Critical Limitation: Lacks Specificity
Because GDH is present in both toxigenic (disease-causing) and non-toxigenic (harmless) C. difficile strains, a positive GDH test alone cannot diagnose infection 2, 1. Studies show that up to 46% of C. difficile isolates may be non-toxigenic 2, meaning they colonize without causing disease.
Role in Multi-Step Diagnostic Algorithms
GDH serves as the initial screening step in 2- and 3-step diagnostic algorithms 1:
- High sensitivity (0.911) makes it excellent for ruling out infection when negative 3
- Low specificity (0.912) requires confirmatory testing when positive 3
- Must be combined with toxin testing (EIA for toxins A/B) and/or molecular testing (NAAT for toxin genes) 1
The 2018 IDSA/SHEA guidelines position GDH testing within multi-step algorithms that balance sensitivity, specificity, and cost-effectiveness 1. A GDH/NAAT-based algorithm yields sensitivity of 0.91-0.98 and specificity of 0.96-0.98 2.
Performance Characteristics
According to meta-analysis of 42 studies 3:
- Sensitivity: 0.911 (95% CI: 0.871-0.940)
- Specificity: 0.912 (95% CI: 0.892-0.928)
- Positive likelihood ratio: 10.4
- Negative likelihood ratio: 0.098
- Diagnostic odds ratio: 115
A negative GDH result substantially reduces the probability of CDI but does not completely rule it out 4.
Clinical Pitfalls
- Never use GDH alone for diagnosis - it detects organism presence, not toxin production 1
- Only test symptomatic patients (≥3 unformed stools in 24 hours) - testing asymptomatic patients leads to detecting colonization rather than infection 1
- Do not perform "test of cure" - patients can shed organisms for up to 6 weeks after successful treatment 2
- In IBD patients, low qGDH levels with PCR-only positivity often represent colonization rather than true infection 5
Practical Algorithm
When GDH is positive:
- Immediately perform toxin testing (EIA for toxins A/B) or NAAT for toxin genes
- If toxin test is positive → Treat for CDI
- If toxin test is negative but clinical suspicion remains high → Consider NAAT or repeat testing
- If both GDH and toxin are negative → CDI effectively ruled out
This approach provides rapid results, improved sensitivity compared to toxin EIA alone, and remains economical 1.